These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 35831340)
41. Using narratives to inform the development of a digital health intervention related to COVID-19 vaccination in Black young adults in Georgia, North Carolina and Alabama. Stoner MCD; Tweedy D; Comello MGL; Toval C; Pettifor AE; Larsen MA; Baez A; Maragh-Bass AC; Tolley EE; Browne EN; Anderson L; Muessig KE; Budhwani H; Hightow-Weidman LB Vaccine; 2022 Nov; 40(48):6908-6916. PubMed ID: 36280559 [TBL] [Abstract][Full Text] [Related]
42. Implementing education: Personal communication with a healthcare professional is a critical step to address vaccine hesitancy for people with multiple sclerosis. Panisset MG; Kilpatrick T; Cofré Lizama LE; Galea MP Mult Scler Relat Disord; 2022 Jul; 63():103933. PubMed ID: 35671672 [TBL] [Abstract][Full Text] [Related]
43. The relationship between COVID-19 vaccination status in pregnancy and birthweight. Gaur P; Darwin KC; Kohn JR; Uribe KA; Shippey E; Eke AC Am J Obstet Gynecol MFM; 2023 Sep; 5(9):101057. PubMed ID: 37330010 [TBL] [Abstract][Full Text] [Related]
44. Social vulnerability, COVID-19 impact, and decision making among adults in a low-resource community. Felton JW; Rabinowitz JA; Strickland JC; Maher BS; Summers M; Key K; Johnson JE; Yi R Behav Processes; 2022 Aug; 200():104668. PubMed ID: 35667640 [TBL] [Abstract][Full Text] [Related]
45. Determinants of COVID-19 Vaccine Acceptance and Hesitancy: A Health Care Student-Based Online Survey in Northwest China. Zhang J; Dean J; Yin Y; Wang D; Sun Y; Zhao Z; Wang J Front Public Health; 2021; 9():777565. PubMed ID: 35071162 [No Abstract] [Full Text] [Related]
46. Factors impacting parental uptake of COVID-19 vaccination for U.S. Children ages 5-17. Harris JN; Mauro CM; Morgan TL; de Roche A; Zimet GD; Rosenthal SL Vaccine; 2023 May; 41(20):3151-3155. PubMed ID: 37045680 [TBL] [Abstract][Full Text] [Related]
47. Attitudes Toward COVID-19 Vaccination Among Pregnant Persons in Urban Hospital-Affiliated Practices: Exploring Themes in Vaccine Hesitancy. Gibson A; Rand C; Olson-Chen C Matern Child Health J; 2023 Oct; 27(10):1855-1863. PubMed ID: 37486448 [TBL] [Abstract][Full Text] [Related]
48. Social Attitude to COVID-19 and Influenza Vaccinations after the Influenza Vaccination Season and between the Second and Third COVID-19 Wave in Poland, Lithuania, and Ukraine. Zaprutko T; Kremin Y; Michalak M; Bernatoniene J; Zaprutko L; Hudz N; Stolecka A; Cynar J; Niewczas K; Sprawka J; Skorupska P; Wróbel J; Ratajczak P; Kopciuch D; Paczkowska A; Kus K; Hromovyk B Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206232 [TBL] [Abstract][Full Text] [Related]
49. People's perspectives about COVID-19 vaccination certificate: Findings from a representative Italian sample. Caserotti M; Gavaruzzi T; Girardi P; Sellaro R; Rubaltelli E; Tasso A; Lotto L Vaccine; 2022 Dec; 40(51):7406-7414. PubMed ID: 36068108 [TBL] [Abstract][Full Text] [Related]
50. Veterinarian COVID-19 vaccine uptake was widespread, but safety and efficacy concerns held some back: descriptive results from a survey of AVMA members' perceptions of COVID-19. Benishek LE; Tomasi SE; Pikel L; Golab GC J Am Vet Med Assoc; 2023 Jan; 261(5):678-687. PubMed ID: 36626286 [TBL] [Abstract][Full Text] [Related]
51. Vaccine hesitancy among healthcare workers in low- and middle-income countries during the COVID-19 pandemic: Results from facility surveys across six countries. Baral P; Ahmed T; Amor Fernandez P; Peters MA; Drouard SHP; Muhoza P; Mwinnyaa G; Mwansambo C; Nzelu C; Tassembedo M; Uddin MH; Wesseh CS; Yansane ML; Bergeron JR; Karibwami AD; Lopez Chicheri TIOZ; Ogunlayi MIA; Sieleunou I; Hashemi T; Hansen PM; Shapira G PLoS One; 2023; 18(7):e0288124. PubMed ID: 37418435 [TBL] [Abstract][Full Text] [Related]
52. Attitudes towards COVID-19 vaccination among incarcerated persons in the Federal Bureau of Prisons, June-July 2021. Fukunaga R; Kaplan ZE; Rodriguez T; Hagan L; Aarvig K; Dusseau C; Crockett M; Long M Vaccine; 2023 Jun; 41(24):3604-3610. PubMed ID: 37164822 [TBL] [Abstract][Full Text] [Related]
53. Vaccine hesitancy against COVID-19 vaccine over time in Nigeria. Sato R Vaccine; 2023 Apr; 41(17):2749-2753. PubMed ID: 36959055 [TBL] [Abstract][Full Text] [Related]
54. The psychological and behavioural correlates of COVID-19 vaccine hesitancy and resistance in Ireland and the UK. Walsh JC; Comar M; Folan J; Williams S; Kola-Palmer S Acta Psychol (Amst); 2022 May; 225():103550. PubMed ID: 35259642 [TBL] [Abstract][Full Text] [Related]
55. Vaccine hesitancy and anti-vaccination in the time of COVID-19: A Google Trends analysis. Pullan S; Dey M Vaccine; 2021 Apr; 39(14):1877-1881. PubMed ID: 33715904 [TBL] [Abstract][Full Text] [Related]
56. Association between social vulnerability and COVID-19 vaccination hesitancy and vaccination in pregnant and postpartum individuals. Kiefer MK; Mehl R; Rood KM; Germann K; Mallampati D; Manuck T; Costantine MM; Lynch CD; Grobman WA; Venkatesh KK Vaccine; 2022 Oct; 40(44):6344-6351. PubMed ID: 36167695 [TBL] [Abstract][Full Text] [Related]
57. Children's rates of COVID-19 vaccination as reported by parents, vaccine hesitancy, and determinants of COVID-19 vaccine uptake among children: a multi-country study from the Eastern Mediterranean Region. Khatatbeh M; Albalas S; Khatatbeh H; Momani W; Melhem O; Al Omari O; Tarhini Z; A'aqoulah A; Al-Jubouri M; Nashwan AJ; Adwan G; Altaany Z; Nashwan A; Al-Waqfi K; Abuirsheid L; Ayasreh R; Al Mutairi M; Al-Tammemi AB BMC Public Health; 2022 Jul; 22(1):1375. PubMed ID: 35850675 [TBL] [Abstract][Full Text] [Related]
58. The Impact of Priority Settings at the Start of COVID-19 Mass Vaccination on Subsequent Vaccine Uptake in Japan: One-Year Prospective Cohort Study. Hori D; Takahashi T; Ozaki A; Tabuchi T JMIR Public Health Surveill; 2023 Jul; 9():e42143. PubMed ID: 37235691 [TBL] [Abstract][Full Text] [Related]
60. Differences in COVID-19 vaccination uptake in the first 12 months of vaccine availability in Switzerland - a prospective cohort study. Heiniger S; Schliek M; Moser A; von Wyl V; Höglinger M Swiss Med Wkly; 2022 Mar; 152():w30162. PubMed ID: 35429238 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]